Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3

Daniel Dumont(Ontario Institute for Cancer Research), Lotta Jussila(Ontario Institute for Cancer Research), Jussi Taipale(Ontario Institute for Cancer Research), Athina Lymboussaki(Ontario Institute for Cancer Research), Tuija Mustonen(Ontario Institute for Cancer Research), Katri Pajusola(Ontario Institute for Cancer Research), Martin L. Breitman(Ontario Institute for Cancer Research), Kari Alitalo(Ontario Institute for Cancer Research)
Science
October 30, 1998
Cited by 876

Abstract

Vascular endothelial growth factor (VEGF) is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues. Unlike VEGF, the related VEGF-C stimulates the growth of lymphatic vessels through its specific lymphatic endothelial receptor VEGFR-3. Here it is shown that targeted inactivation of the gene encoding VEGFR-3 resulted in defective blood vessel development in early mouse embryos. Vasculogenesis and angiogenesis occurred, but large vessels became abnormally organized with defective lumens, leading to fluid accumulation in the pericardial cavity and cardiovascular failure at embryonic day 9.5. Thus, VEGFR-3 has an essential role in the development of the embryonic cardiovascular system before the emergence of the lymphatic vessels.


Related Papers

No related papers found

Powered by citation graph analysis